Reply to: 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients'
- PMID: 32057917
- DOI: 10.1016/j.jhep.2020.01.020
Reply to: 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients'
Conflict of interest statement
Conflicts of interest Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.J Hepatol. 2020 Jan;72(1):67-74. doi: 10.1016/j.jhep.2019.09.022. Epub 2019 Oct 8. J Hepatol. 2020. PMID: 31604081 Free PMC article. Clinical Trial.
-
High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients.J Hepatol. 2020 May;72(5):1028-1029. doi: 10.1016/j.jhep.2019.10.018. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147086 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical